Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB.
Department of Epidemiology, Cancer Care Manitoba, Winnipeg, MB; Cancer Care Manitoba Research Institute, Winnipeg, MB.
J Obstet Gynaecol Can. 2022 May;44(5):475-481. doi: 10.1016/j.jogc.2021.10.010. Epub 2021 Oct 28.
To evaluate the incidence of venous thromboembolism (VTE) in 90-day pre-operative period and at 30 and 90 days post surgery in patients who underwent debulking for ovarian cancer, analyze the impact of extended prophylaxis that was initiated in 2012, and examine the influence of data collection technique on reported rates of VTE.
This retrospective database and records study examined rates of VTE in epithelial ovarian cancer patients in Manitoba, Canada between 2004 and 2016. Cases of VTE were identified using ICD codes, drug prescriptions, and records reviews; 4 different data collection methods were used. Analysis was performed with analysis of variance, Kruskal-Wallis and χ tests, and interrupted time series models.
Data collection identified 823 debulking surgeries, with a final cohort of 779 patients; data were analyzed before and after extended prophylaxis intervention. Overall rates of VTE varied by collection method and were 1.82%-5.47%, 0.36%-3.16%, 0.85%-1.46%, and 1.46%-2.79%, respectively. During this timeframe, we noted a significant increase in the use of neoadjuvant chemotherapy (P = 0.010) and stage migration to stage 3 (P < 0.001).
We report the rates of VTE utilizing 4 different data collection methods. We found a low overall rate, with some trends requiring further investigation. This study highlights the importance of data collection method on the reported rates of VTE in research.
评估行卵巢癌肿瘤细胞减灭术患者术前 90 天、术后 30 天和 90 天静脉血栓栓塞症(VTE)的发生率,分析 2012 年开始实施的延长预防方案的影响,并研究数据收集技术对报告 VTE 发生率的影响。
本回顾性数据库和病历研究调查了 2004 年至 2016 年间加拿大马尼托巴省上皮性卵巢癌患者的 VTE 发生率。使用国际疾病分类(ICD)代码、药物处方和病历回顾来识别 VTE 病例;使用了 4 种不同的数据收集方法。采用方差分析、Kruskal-Wallis 和 χ 检验以及中断时间序列模型进行分析。
数据收集共确定了 823 例肿瘤细胞减灭术,最终纳入了 779 例患者;在延长预防方案干预前后进行数据分析。VTE 的总体发生率因收集方法而异,分别为 1.82%至 5.47%、0.36%至 3.16%、0.85%至 1.46%和 1.46%至 2.79%。在此期间,我们注意到新辅助化疗的使用率显著增加(P=0.010),以及疾病分期向 3 期迁移(P<0.001)。
我们利用 4 种不同的数据收集方法报告了 VTE 发生率。我们发现总体发生率较低,一些趋势需要进一步调查。本研究强调了数据收集方法对研究中报告 VTE 发生率的重要性。